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Introduction: Lipodystrophy is still a matter of concern in HIV patients receiving ART. However, long-term fat change in
patients taking non-thymidine regimens is not well known.
Materials and Methods: A prospective ongoing fat change assessment including clinical evaluation and dexa scans (Hologic QDR
4500) is being conducted in all consecutive patients initiating ART from January 2008. Arm, leg, trunk and total fat as well as fat
mass ratio (FMR% trunk fat/% leg fat) were determined. Patients with data at baseline (BL), 12 and 36 m are included in this
analysis. ITT and OT were performed. Multivariate general linear models were used to assess changes in fat measures.
Results: One hundred patients were included. 81% men, 42.9 years, 18% AIDS, CD4 218.5 (6-756), viral load 5 log (2.9-6.8), leg
fat 4644g, trunk fat 6693g, FMR 0.94. Around 40 patients (40%) initiated a PIr (17 LPVr, 11 ATVr, 9 DRVr, 3 FPVr), 34 (34%) NVP
and 21 (21%) EFV. About 83% received TDF/FTC and 10% ABC/3TC. Groups were comparable at BL except for a lower viral load in
NVP patients (p0.047) and lower c-LDL in PI patients (p0.043). After 36 m, no patient presented a clinically evident
lipodystrophy. At 12 m, an overall significant increase was found from baseline in trunk, leg and FMR (median 759 g, 479.4 g and
0.03, respectively, pB0.05) and at 36 m in trunk and leg fat (median 989.9 g, 566 g, respectively, pB0.05). According to ART, at
12 m a significant increase in trunk and leg fat was observed in EFV and PIr. At 36 m, in NVP patients trunk and leg fat as well as
FMR increased, whereas in PIr patients only leg fat increased (see figure). In ITT analysis, adjusted by age, sex, risk practice and
BL CD4, EFV was associated with a greater increase in FMR (p0.036) at 36 m vs PIr. In OT analysis, at 12 m, NVP was associated
with a smaller percentage increase in trunk fat (vs PIr and EFV, p0.006) and in leg fat (vs PIr, p0.046). These differences did
not persist at 36 m.
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Figure 1. Changes in Trunk fat, Leg fat and FMR at 12 and 36 months, according to ART.
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Conclusions: In this cohort of patients taking non-thymidine-based regimens, after 36 m without a clinically evident
lipodystrophy, no significant changes in FMR were observed. However, some differences in fat redistribution according to ART
were present: PIr was associated with an initial and continuous increase in trunk and leg fat, NVP with a slower and progressive
increase in both fat compartments, while in EFV patients, the initial fat increase was followed by a decrease in peripheral fat at
36 m. Longer follow up will help to confirm these trends.
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